Damage of the kinesin heavy chain gene contributes to the antagonism of cisplatin and paclitaxel

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 3211-3219

  Efferth, T ^a   Fabry, U ^a   Osieka, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antisense oligodeoxynucleotides; Apoptosis; Chemotherapy; DNA damage

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; CISPLATIN; KINESIN; MONOCLONAL ANTIBODY; PACLITAXEL;

APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION; GENETIC DAMAGE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CISPLATIN; DNA DAMAGE; DRUG ANTAGONISM; HUMANS; K562 CELLS; KINESIN; OLIGONUCLEOTIDES, ANTISENSE; PACLITAXEL;

EID: 0033786096     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Taxol stabilizes microtubules in mouse fibroblast cells
2. Paclitaxel (Taxol)
3. Cisplatin update
4. Sequences of taxol and cisplatin: A phase I and pharmacological study
5. Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine
6. Sequence dependence of paclitaxel (taxol(R)) combined with cisplatin or alkylators in human cancer cells
7. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro
8. The formation, isolation and characterisation of DNA adducts produced by anticancer platinum complexes
9. A polymerase chain reaction-based method to detect cisplatin adducts in specific genes
10. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor)
11. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA
12. Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization
13. Molecular phylogeny of the kinesin family of microtubule motor proteins
14. The quaternary structure of bovine brain kinesin
15. The role of kinesin and other soluble factors in organelle translocation along microtubules
16. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257
17. Comparative evaluation of several DNA binding dyes in the detection of apoptosis associated chromatin degradation by flow cytometry
18. Features of apoptotic cells measured by flow cytometry
19. UICC study group on basic and clinical cancer research: Apoptosis in normal and tumour cells
20. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells
21. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
22. Suppression of kinesin expression in cultured hippocampal neurons using antisense oligonucleotides
23. Inhibition of kinesin-driven microtubule motility by monoclonal antibodies to kinesin heavy chains
24. Gene-specific damage produced by cisplatin, ormaplatin and UV light in human cells as assayed by the polymerase chain reaction
25. Sample preparation from blood, cells and other fluids
26. Cloning and expression of a human kinesin heavy chain gene: Interaction of the COOH-terminal domain with cytoplasmic microtubules in transfected CV-1 cells
27. Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand confirmation polymorphism analysis
28. DNA repair in cisplatin-sensitive and resistant human cell lines measured in specific genes by quantitative polymerase chain reaction
29. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoprotein
30. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-π gene in human glioblastoma cells
31. mRNA phenotyping by enzymatic amplification of randomly primed cDNA
32. Detection of keratinocyte growth factor (KGF) transcripts from normal and archival canine benign prostatic hyperplastic tissues
33. Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro
34. Activity and schedule-dependent interactions of paclitaxel, etoposide and hydroxyperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines
35. Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: Mapping of the domain associated with drug response
36. Does antisense exist?
37. Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin-2
38. Two mechanisms for IgG uptake in cultured human trophoblast: Evidence for a novel high affinity Fc receptor
39. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II)
40. Spectrum of DNA-platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases
41. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents
42. Microtubule-active drugs taxol, vinblastine and nocodazole increase the levels of transcriptionally active p53
43. Mutational inactivation of the p 53 gene in the human erythroid leukemic K562 cell line
44. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
45. Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153